Hila Cohen
Merkaz Hakarmel, HA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Hormonal contraceptives and cancer risk in women with a BRCA1 or BRCA2 pathogenic variant.
Journal: Breast cancer (Tokyo, Japan)
Published: January 16, 2026
The prognostic value of pre-implantation hyponatremia in pacemaker recipients: A population-based study.
Journal: Journal of cardiology
Published: August 18, 2025
The mRNA component of LNP-mRNA vaccines triggers IFNAR-dependent immune activation which attenuates the adaptive immune response.
Journal: Frontiers in immunology
Published: July 21, 2025
Novel Bivalent mRNA-LNP Vaccine for Highly Effective Protection against Pneumonic Plague.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 20, 2025
A Novel Virulent Clinical Isolate of Burkholderia pseudomallei Imported from Thailand Exhibiting Resistance to Trimethoprim-Sulfamethoxazole.
Journal: The American journal of tropical medicine and hygiene
Published: April 10, 2024
A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium.
Journal: Science advances
Published: March 08, 2023
Cellular and humoral response to the fourth BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL.
Journal: European journal of haematology
Published: September 05, 2022
Humoral and T-Cell Response before and after a Fourth BNT162b2 Vaccine Dose in Adults ≥60 Years.
Journal: Journal of clinical medicine
Published: March 24, 2022
Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice.
Journal: Vaccines
Published: March 16, 2022
T Cell Response following Anti-COVID-19 BNT162b2 Vaccination Is Maintained against the SARS-CoV-2 Omicron B.1.1.529 Variant of Concern.
Journal: Viruses
Published: January 16, 2022
Last Updated: 09/26/2026